J Korean Neurosurg Soc.  1980 Sep;9(2):357-368.

Experimental Microneurosurgical Cerebral Embolectomy:A Time Limit for Cerebral Embolectomy

Affiliations
  • 1Department of Neurological Surgery, Ewha Womans University College of Medicine, Seoul, Korea.

Abstract

Acute cerebral embolism continues to be a major cause of stroke morbidity in children and young adults. A variety of drugs including steroids, dextran, barbiturates, and anticoagulants are used in the management of cerebral ischemia, despite controversy over their benefits in clinical and experimental situations. The operative treatment includes microsurgical cerebral embolectomy and cerebral revascularization. Middle cerebral artery embolectomies which have been carried out in human with variable results, have been reported by different authors. In order to define a time limit for cerebral embolectomies before irreversible brain damage has been incurred, the canine middle cerebral artery was embolized by means of a gutta percha cylinder, 4 mm long by 1.5 mm in diameter, via the internal carotid artery. It was observed that embolectomy of the middle cerebral artery performed between 4 and 5 hours postembolism could prevent the expected cerebral infarction effectually. Middle cerebral artery embolectomy beyond 5-hour periods invariably resulted in severe hemorrhagic infarction with concomitant neurological impairment.


MeSH Terms

Anticoagulants
Barbiturates
Brain
Brain Ischemia
Carotid Artery, Internal
Cerebral Infarction
Cerebral Revascularization
Child
Dextrans
Embolectomy*
Gutta-Percha
Humans
Infarction
Intracranial Embolism
Middle Cerebral Artery
Steroids
Stroke
Young Adult
Anticoagulants
Barbiturates
Dextrans
Gutta-Percha
Steroids
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr